Tweet
Anyone know whether Epicentre 'an Illumina company' is discontinuing all 454 Nextera library products now that they are selling an updated Illumina version directly? Could not find any info on either site about it.
-
-
The answer
From our sales rep: "I was able to confirm to day that this kit is being discontinued as of May 2012. The final decision was made yesterday and an email will be sent to all of the customer base within the next day or two. Regards..."
And probably the protocol is patented so no other company can take up the slack.
-
Nextera DNA Sample Prep Kits (Roche 454-Compatible) will be available for sale through Epicentre Customer Service until May 31, 2012, with final shipments required by June 30, 2012. This transition period will allow existing customers using these kits to complete ongoing projects without interruption.Comment
-
HMorrison,
Please contact me regarding these kits as well as your AmpureXP inconsistency issues.
Thanks a bunch!
MichaelComment
-
I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.
Here are nine questions we think about, in roughly the order they matter, before...Yesterday, 07:11 AM -
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM
Comment